1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Female: new trials by email Literature Review of Female trials Research Report on Female
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dostarlimab, Cisplatin and Etoposide in Combination With Radiotherapy in Sandwich Sequence for Small Cell Neuroendocrine Cervical Carcinoma Dostarlimab - Female | Phase 2 | Recruiting | Chang Gung Memorial Hospital | 45 | 2025-12-22 | 2026-08-17 |
| 99mTc-ADAPT6 SPECT-based Non-invasive Quantification of HER2-expression in Breast Cancer With Metastatic Lymph Nodes ADAPT6-SPECT - Breast Cancer, Female | Phase 2 | Completed | Tomsk National Research Medical Center of the Russian Academy of Sciences | 30 | 2022-05-01 | 2026-06-24 |
Breast Neoplasms (1) · Uterine Cervical Neoplasms (1)
Neoplasms (2) · Neoplasms by Site (2) · Breast Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1) · Uterine Cervical Diseases (1) · Uterine Diseases (1) · Uterine Neoplasms (1)
Cisplatin (1) · Etoposide (1) · Radiotherapy (1) · dostarlimab (1)
Chang Gung Memorial Hospital (1) · Tomsk National Research Medical Center of the Russian Academy of Sciences (1)
Russia (1) · Taiwan (1)